Versant Venture Capital VI, L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), bought 635,099 shares at $16.00 ($6.4M) on 2019-06-24, disclosed to the SEC on 2019-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 235,099 | $0 | 0.0% |
| 2 | $16.00 | 400,000 | $6.4M | 100.0% |
| Total | $10.08 avg | 635,099 | $6.4M | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |